Trends in Use and Effects of Synthetic Cannabinoids and Cathinones Pre- and Post-Amendment of the Controlled Substance Act in 2012
| dc.contributor.advisor | Bellestri, Robyn L. | en |
| dc.contributor.advisor | Goldstone, Lisa | en |
| dc.contributor.author | Hayes, John | |
| dc.contributor.author | Bellestri, Robyn L. | |
| dc.contributor.author | Goldstone, Lisa | |
| dc.date.accessioned | 2016-06-22T19:53:34Z | |
| dc.date.available | 2016-06-22T19:53:34Z | |
| dc.date.issued | 2014 | |
| dc.identifier.uri | http://hdl.handle.net/10150/614187 | |
| dc.description | Class of 2014 Abstract | en |
| dc.description.abstract | Specific Aims: To compare trends in user demographics, clinical effects, and clinical outcomes associated with the use of synthetic cannabinoids and cathinones before and after signing into law the Synthetic Drug Abuse Prevention Act of 2012 on July 9, 2012. Methods: Reports generated by the National Poison and Drug Information Center’s Toxic Exposure Surveillance System were used to isolate calls regarding patients who reportedly used either synthetic cannabinoids or synthetic cathinones from July 2011 to March 2013. Clinical effects, clinical outcomes, and demographic information of patients associated with these calls from July 9, 2011 to July 8, 2012, were compared to that of patients associated with calls from July 9, 2012 to July 8, 2013. Main Results: Pending Conclusion: Pending | |
| dc.language.iso | en_US | en |
| dc.publisher | The University of Arizona. | en |
| dc.rights | Copyright © is held by the author. | en |
| dc.rights.uri | http://rightsstatements.org/vocab/InC/1.0/ | |
| dc.subject | Cannabinoids | en |
| dc.subject | Cathinones | en |
| dc.subject | Controlled Substance Act | en |
| dc.subject | Effects | en |
| dc.subject.mesh | Street Drugs | |
| dc.subject.mesh | Cannabinoids | |
| dc.title | Trends in Use and Effects of Synthetic Cannabinoids and Cathinones Pre- and Post-Amendment of the Controlled Substance Act in 2012 | en_US |
| dc.type | text | en |
| dc.type | Electronic Report | en |
| dc.contributor.department | College of Pharmacy, The University of Arizona | en |
| dc.description.collectioninformation | This item is part of the Pharmacy Student Research Projects collection, made available by the College of Pharmacy and the University Libraries at the University of Arizona. For more information about items in this collection, please contact Jennifer Martin, Librarian and Clinical Instructor, Pharmacy Practice and Science, jenmartin@email.arizona.edu. | en |
| html.description.abstract | Specific Aims: To compare trends in user demographics, clinical effects, and clinical outcomes associated with the use of synthetic cannabinoids and cathinones before and after signing into law the Synthetic Drug Abuse Prevention Act of 2012 on July 9, 2012. Methods: Reports generated by the National Poison and Drug Information Center’s Toxic Exposure Surveillance System were used to isolate calls regarding patients who reportedly used either synthetic cannabinoids or synthetic cathinones from July 2011 to March 2013. Clinical effects, clinical outcomes, and demographic information of patients associated with these calls from July 9, 2011 to July 8, 2012, were compared to that of patients associated with calls from July 9, 2012 to July 8, 2013. Main Results: Pending Conclusion: Pending |